# Primary Thrombocythaemia 1 Trial

> **NCT00175838** · NA · COMPLETED · sponsor: **University of Cambridge** · enrollment: 1398 (actual)

## Conditions studied

- Thrombocythemia
- Myeloproliferative Disorder

## Interventions

- **DRUG:** Hydroxyurea
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT00175838
- **Lead sponsor:** University of Cambridge
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-07
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 1398 (ACTUAL)
- **Last updated:** 2017-01-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00175838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00175838, "Primary Thrombocythaemia 1 Trial". Retrieved via AI Analytics 2026-09-23 from https://api.ai-analytics.org/clinical/NCT00175838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*